Trial intelligence / Profile preview

Efficacy and Safety of 4-Phasic Oral Contraceptive SH T00658

NCT00185289Phase 3Completed

Sponsor
Bayer
Start
Apr 2004
Modality
Small Molecules
Countries
3
01

Overview

A Phase 3 trial of estradiol valerate, dienogest in contraception, sponsored by Bayer. Started Apr 2004; status: completed.

02

Drugs

estradiol valeratedienogest
03

Conditions

contraception

Beyond the preview

Go deeper on NCT00185289.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00185289.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call